DADE ACTIN FSL B4219-2 SMN 10445714

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2017-02-16 for DADE ACTIN FSL B4219-2 SMN 10445714 manufactured by Siemens Healthcare Diagnostics Products Gmbh.

Event Text Entries

[67544448] The cause of the discordant elevated aptt result is unknown. The customer stated that quality control was within laboratory ranges and there have been no issues with other patient samples. After the 180. 7 seconds result was reported, the account stated that they notified the nurse that they were unable to report further aptt results on this patient due to interfering substances in the sample as they are not sure which result is correct. The siemens headquarters support center (hsc) representative evaluated the information provided. The discordant elevated result of 2:54 am (b)(6) 2017 of 180. 7 raw seconds is a prolonged value and is consistent with ufh therapy. The patient sample was noted as slightly lipemic. Aptt testing was requested to monitor the patient for unfractionated heparin (ufh) therapy. The bcs xp system performed as expected, sample result flags were appropriately generated. The laboratory followed manufacturer's guidelines as well as good laboratory practice and all reported values on the patient were appropriate. The laboratory proactively informed the physician of the challenge with obtaining consistent aptt results on this patient due to a potential interfering substance. The physician elected to use an alternate anticoagulant, argatroban. Aptt testing since this time has been consistent and reportable. There is no report of harm to the patient. This is an isolated incident and there is no evidence of a systemic product non-conformance. The device is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


[67544449] A discordant elevated activated partial thromboplastin time (aptt) result was obtained on a patient sample run with the actin fsl reagent on the bcs-xp analyzer. The elevated result was reported to the physician. The patient anticoagulant treatment was altered on the basis of the discordant elevated aptt result. The patient was taken off heparin treatment and switched to the anticoagulant argatroban. There is no indication of adverse health consequences to the patient on the basis of the discordant elevated aptt result or the change in anticoagulant treatment.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9610806-2017-00023
MDR Report Key6335159
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2017-02-16
Date of Report2017-02-16
Date of Event2017-01-17
Date Mfgr Received2017-01-17
Device Manufacturer Date2016-01-20
Date Added to Maude2017-02-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJAMES MORGERA
Manufacturer StreetGLASGOW BUSINESS COMMUNITY 500 GBC DRIVE PO BOX 6101
Manufacturer CityNEWARK DE 197146101
Manufacturer CountryUS
Manufacturer Postal197146101
Manufacturer Phone3026318356
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer StreetEMIL VON BEHRING STRASSE 76
Manufacturer CityMARBURG, D-35041
Manufacturer CountryGM
Manufacturer Postal CodeD-35041
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDADE ACTIN FSL
Generic NameDADE ACTIN FSL ACTIVATED PTT REAGENT
Product CodeGGW
Date Received2017-02-16
Catalog NumberB4219-2 SMN 10445714
Lot Number547475
Device Expiration Date2018-01-03
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer AddressEMIL VON BEHRING STRASSE 76 MARBURG, D-35041 GM D-35041


Patients

Patient NumberTreatmentOutcomeDate
10 2017-02-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.